Featured Fireside Chat

In April of this year, Takeda Pharmaceutical, Japan’s largest drug company purchased Millennium Pharmaceuticals, one of the earliest American genomics companies for nearly $9 billion providing Takeda an entry into the cancer-drug market. During this off-the-record discussion, topics will include:

• Important criteria each company sought in a strategic partner
• Communicating effectively through cultural differences
• Lessons learned during the due diligence process
• Approach for successful integration of the two companies

Presenters included:

• Gabor Garai, Co-Chair, Life Sciences Industry Team, Foley
• Dr. Daniel Curran, Vice President, Corporate Development, Millennium Pharmaceuticals Inc.
• Catherine Sazdanoff, Vice President, Global Licensing, Takeda Pharmaceuticals North America, Inc.